Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | VKTX | ACAD | ||
| Company | Rayzebio Inc | Viking Thera | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.49 | 32.38 | 20.82 | ||
| High | 62.50 | 32.76 | 21.07 | ||
| Low | 62.48 | 31.71 | 20.36 | ||
| Latest | 62.49 | 32.17 | 20.96 | ||
| Change | +0.01 | -0.38 | -0.03 | ||
| % Change | +0.02% | -1.17% | -0.14% | ||
| Volume | 282,700 | 2,290,300 | 1,989,900 | ||
| 20-Day Average Volume | 318,060 | 2,385,305 | 2,113,920 | ||
| Previous Close | 62.48 | 32.55 | 20.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 33.65 | 22.12 | ||
| 20-Day Raw Stochastic | 95.83% | 27.09% | 19.56% | ||
| 20-Day Relative Strength | 86.10 | 47.52 | 39.62 | ||
| Weighted Alpha | N/A | +44.31 | +3.90 | ||
| Today's Opinion | N/A | Hold | 72% Sell | ||
| Previous Opinion | N/A | 24% Buy | 72% Sell | ||
| Last Month's Opinion | N/A | 32% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -9.46% since 03/17/26 | +0.29% since 03/17/26 | ||
| Low | 62.42 on 02/16/24 | 31.49 on 03/20/26 | 19.89 on 03/19/26 | ||
| High | 62.51 on 02/22/24 | 35.39 on 03/18/26 | 21.51 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -4.68% since 02/24/26 | -14.76% since 02/24/26 | ||
| Low | 61.86 on 01/24/24 | 30.19 on 03/05/26 | 19.89 on 03/19/26 | ||
| High | 62.51 on 02/22/24 | 37.50 on 03/13/26 | 25.36 on 02/27/26 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | -13.87% since 12/24/25 | -24.79% since 12/24/25 | ||
| Low | 22.14 on 11/27/23 | 25.77 on 02/05/26 | 19.89 on 03/19/26 | ||
| High | 62.51 on 02/22/24 | 37.50 on 03/13/26 | 27.95 on 12/26/25 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | +20.80% since 09/24/25 | -1.41% since 09/24/25 | ||
| Low | 17.95 on 09/26/23 | 24.88 on 09/26/25 | 19.69 on 10/13/25 | ||
| High | 62.51 on 02/22/24 | 43.15 on 11/12/25 | 28.35 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,761,283 | 3,578,690 | ||
| Shares Outstanding, K | 59,920 | 115,554 | 170,495 | ||
| Annual Sales | 0 | 0 | 1,071,510,000 | ||
| Annual Net Income | -68,600,000 | -359,640,000 | 391,000,000 | ||
| Last Quarter Sales | 0 | 0 | 283,990,000 | ||
| Last Quarter Net Income | -18,190,000 | -157,660,000 | 273,570,000 | ||
| 60-Month Beta | N/A | 0.75 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | -1.38 on 02/11/26 | 0.16 on 02/25/26 | ||
| Latest Earnings Date | 03/04/24 | 04/22/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 30.06 | ||